Hence, the identification of important genetic polymorphisms such as NLRP3 (rs4612666) and IL-1β (+3954) will pave the way for the development of point of care treatment for patients suffering from periodontitis and coronary heart disease. The gene discussed is NLRP3; the disease is coronary artery disorder.